Azacitidine unlikely to be cost effective for AML in Canada Clinical study 05 October 2019 Pages: 3 - 3
Ceftazidime/avibactam against drug-resistant Enterobacteriaceae Clinical study 05 October 2019 Pages: 4 - 4
Concern over QOL data in cancer drug reimbursement submissions Non-clinical study 05 October 2019 Pages: 7 - 7
Examining US cancer drug prices per survival gain 1995−2017 Clinical study 05 October 2019 Pages: 10 - 10
Fluticasone furoate/vilanterol: better asthma control reduces cost Clinical study 05 October 2019 Pages: 11 - 11
Genotyping for breast cancer endocrine therapy cost effective Clinical study 05 October 2019 Pages: 12 - 12
High cost of acute graft-vs-host disease after cell transplant Clinical study 05 October 2019 Pages: 13 - 13
Is surgery with mesh cost effective for pelvic organ prolapse? Clinical study 05 October 2019 Pages: 15 - 15
Is surveillance colonoscopy cost effective after adenoma removal? Clinical study 05 October 2019 Pages: 16 - 16
Minimum unit pricing reduces alcohol purchases in Scotland Clinical study 05 October 2019 Pages: 18 - 18
Multigene testing in acute coronary syndrome optimises drug therapy Clinical study 05 October 2019 Pages: 19 - 19
NHS costs similar with oral bedaquiline and injectable therapy Clinical study 05 October 2019 Pages: 20 - 20
Osimertinib in EGFR-mutated NSCLC: better outcomes, high cost Clinical study 05 October 2019 Pages: 21 - 21
Pembrolizumab for PD-L1+ NSCLC cost effective in Hong Kong Clinical study 05 October 2019 Pages: 22 - 22
Pharmacoeconomic evaluation in Ireland: review of process, timeline Non-clinical study 05 October 2019 Pages: 23 - 23
Prenatal screening for congenital toxoplasmosis worth extra cost Clinical study 05 October 2019 Pages: 25 - 25
Stringent glycaemic control not cost effective in all patients Clinical study 05 October 2019 Pages: 27 - 27
Suicide-prevention campaign cost effective in Ontario, Canada Clinical study 05 October 2019 Pages: 28 - 28
Tafenoquine cost-effective option in Plasmodium vivax malaria Clinical study 05 October 2019 Pages: 29 - 29
Type 1 diabetes drives costs of autoimmune polyendocrinopathy Clinical study 05 October 2019 Pages: 30 - 30
Understanding the true cost of delirium: a study from Australia Clinical study 05 October 2019 Pages: 31 - 31
Alternative funding considered for cystic fibrosis drug in England News item 05 October 2019 Pages: 33 - 33
Gut malabsorption, limb spasticity drugs included on Australian PBS News item 05 October 2019 Pages: 34 - 34